CLINICAL AND MORPHOLOGICAL RATIONALE FOR THE ULIPRISTAL ACETATE PRE-OPERATION TREATMENT BEFORE ORGANPRESERVING OPERATIONS IN MYOMAS UTERUS PATIENTS WITH THE INTRAUTERINE BLEEDING AND ANAEMIA
Objective: assessment of the feasibility and safety of the use of ulipristal acetate on the basis of the clinical and morphological study.Materials and methods: the study involved 78 women with leiomyoma, abundant menstruation and anemia. Group I – 43 patients who underwent ulipristal acetate therap...
Main Authors: | A. V. Kozachenko, Z. V. Revazova, L. V. Adamyan, T. A. Demura |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1978 |
Similar Items
-
Hormonal assessment of patients of reproductive age with uterine myoma for surgical treatment
by: A. V. Kozachenko, et al.
Published: (2019-10-01) -
Ulipristal acetate before high complexity endoscopic (hysteroscopic, laparoscopic) myomectomy – a mini-review
by: Włodzimierz Baranowski
Published: (2017-02-01) -
New Concepts in the Therapeutic Management of Myoma
by: Friederike Hoellen, et al.
Published: (2015-08-01) -
Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
by: Iwona Szydłowska, et al.
Published: (2020-01-01) -
First clinical-morphological tendencies of the treatment ofpatients with myoma of womb with ulipristal acetate
by: A L Tikhomirov, et al.
Published: (2014-04-01)